Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Choline Substitution in Cystic Fibrosis Liver Steatosis
NCT03312140Completed
- Sponsor
- University Hospital Tübingen
- Start
- Nov 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of choline chloride in cystic fibrosis-associated liver disease (CFLD), sponsored by University Hospital Tübingen. Primary endpoint: Measurement of D9-Methyl-Choline Kinetic at 3 months. Started Nov 2014; status: completed.
02
Drugs
choline chloride
03
Conditions
cystic fibrosis-associated liver disease (CFLD)
Beyond the preview
Go deeper on NCT03312140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03312140.